Sharing: China NMPA’s working procedure for overseas Drug Inspections
On December 26, 2018, China NMPA (National Medical Products Administration) released the Regulations for Drug and Device Overseas Inspection. Drugs and devices that have been approved or are applying for market in China are subject to this Regulation. The working procedure are summarized in the diagram below. And in the first half of 2019, there…